ea0083cbo3 | Calcium and Bone | EYES2022
D Ferrari
, V Sada
, V Hasenmajer
, D De Alcubierre
, G. Puliani
, M Minnetti
, A Cozzolino
, A Tomaselli
, R Pofi
, A Lenzi
, A Isidori
Background: Patients with adrenal insufficiency (AI) require long-term glucocorticoid (GC) replacement therapy and generally show an increased prevalence of bone metabolism alterations. Only few data are available on bone safety of dual-release Hydrocortisone (DR-HC) therapy. Objective: To evaluate bone metabolism in primary AI (PAI) and secondary AI (SAI) during long-term therapy with DR-HC.Methods: We evaluated patients with AI o...